In conclusion, the results of our meta-analysis suggest that a significant association was found between the MMP-2-1306 C/T and MMP-9-1562 C/T polymorphisms and the risk of bladder cancer, while the MMP-9-1562 C/T polymorphism is not associated with bladder cancer. Here, MMP9 is linked to urinary bladder carcinoma.